Info: Available in Capsules or Powder Form
L-Lysine is an essential amino acid, which means our bodies need it but cannot produce it on our own – it must be obtained through the diet or by supplementation. Lysine is one of the most well-known amino acids and is an essential component of all proteins.
Info: Available in Capsules or Powder Form
L-Lysine is an essential amino acid, which means our bodies need it but cannot produce it on our own – it must be obtained through the diet or by supplementation. Lysine is one of the most well-known amino acids and is an essential component of all proteins.
Product Notes:
Among other benefits, L-Lysine has virus-fighting abilities which can help reduce the recurrence of herpes simplex virus (HSV) infections (such as cold sores), and it also helps form collagen for bone, cartilage and connective tissue.
L-Lysine is available in 500 mg capsules, in two bottle sizes, and in a 100% pure powdered form.
Ingredients:
Each L-Lysine capsule (Health Canada Natural Product Number 80002648) contains:
500 mg L-Lysine (from Lysine Monohydrochloride)
Non-medicinal ingredients: Capsule (gelatin, water), Stearic Acid (vegetable source), Cellulose, Magnesium Stearate (vegetable source), Rice flour.
Each 1/4 teaspoon of the L-Lysine Powder (NPN 80002663) contains:
552 mg L-Lysine (from Lysine Monohydrochloride). No other ingredients.
Suggested Usage:
Adults: Take 2 Capsules 1 to 3 times daily, between meals. Consult a healthcare practitioner for use beyond 6 months.
Powder: For Calcium Absorption: Adults: Take 1/4 teaspoon, 2 times daily, between meals. Consult a healthcare practitioner for prolonged use.
For Cold Sores: Adults, Take 2-1/4 teaspoons, 3 times daily, between meals. Do not use longer than 6 months.
Store either type in a cool, dry place.
Warnings:
Consult a healthcare practitioner prior to using NOW Foods L-Lysine if you are pregnant or breastfeeding, or if you are following a low protein diet. Consult a healthcare practitioner if symptoms persist.
Supporting Science:
Pedrazini, Maria Cristina et al. “L-lysine: Its antagonism with L-arginine in controlling viral infection. Narrative literature review.” British Journal of Clinical Pharmacology, 2022.
Pedrazini, Maria Cristina, and Francisco Carlos Groppo. “L-lysine therapy to control the clinical evolution of pityriasis rosea: Clinical case report and literature review.” Dermatologic Therapy, 2021.
Stagi, Luigi et al. “Blocking viral infections with lysine-based polymeric nanostructures: a critical review.” Biomaterials Science, 2022.
Product Options: